
Gian Life Care Ltd to Approve Q3 and Q4 Financial Results on 21st February, 2026
Gian Life Care Ltd has announced that its Board of Directors will meet on 21st February, 2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarters ended 30th September, 2025 and 31st December, 2025. The meeting will take place in Kanpur. The trading window for dealing in shares of the company has been closed from 1st October, 2025 for all Directors, KMP’s, Designated Employees and Connected Persons of the Company as defined in the Code, and will remain closed till 48 hours after the information is made public.
Key Highlights
- Gian Life Care Ltd to consider and approve Unaudited Standalone and Consolidated Financial Results for Q3 and Q4 2025
- Board Meeting scheduled on 21st February, 2026 in Kanpur
- Trading window for dealing in shares closed from 1st October, 2025
Price Impact
More from GIANLIFE
Gian Life Care Ltd Enters Hospital Lab Management Services Agreement with Brahma Hospital (HUF)
Gian Life Care Ltd Announces Q3 2025 Results with ¥ 743.78 Lakhs Cash Balance and Unpaid Dues
Gian Life Care Ltd. Approves Q3 Results with Cash Balance of ₹ 743.78 Lakhs and Unpaid Dues of ₹ 426.66 Lakhs and ₹ 359.78 Lakhs